Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Neuroleptic malignant syndrome: a case report and discussion (CROSBI ID 306453)

Prilog u časopisu | stručni rad | domaća recenzija

Grabovac, Vlatko ; Žiga, Sead ; Kereš, Tatjana ; Sorić, Maša Neuroleptic malignant syndrome: a case report and discussion // Signa Vitae, 9 (2014), 1; 88-90

Podaci o odgovornosti

Grabovac, Vlatko ; Žiga, Sead ; Kereš, Tatjana ; Sorić, Maša

engleski

Neuroleptic malignant syndrome: a case report and discussion

Neuroleptic malignant syndrome (NMS) is an emergent, life threatening condition most often seen as an iatrogenic complication of neuroleptic or antipsychotic treatment. It is characterized by a tetrad of clinical features: mental status changes, fever, muscle rigidity and autonomic instability, although it is not necessary for all of them to be present at a same time for working diagnosis to be made. This paper will deal with the case of a 29-year old male patient diagnosed with schizophrenia who developed NMS, presented as a generalized tonic-clonic seizure and high fever, after 191 days of in-hospital treatment. After 13 days of hospital treatment in the Intensive Care Unit of Clinical Hospital Dubrava, the patient is in a hemodynamical and proper quantitative mental state and discharged for further psychiatric treatment at his parent hospital institution.

neuroleptic malignant syndrome, neuroleptics, creatine kinase

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

9 (1)

2014.

88-90

objavljeno

1334-5605

1845-206X

Povezanost rada

Povezane osobe



nije evidentirano

Indeksiranost